SAIGENE CORP has a total of 29 patent applications. Its first patent ever was published in 1996. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets biotechnology, machines and measurement are PRIMERA BIOSYSTEMS INC, ENZO DIAGNOSTICS INC and KURN NURITH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Australia | 6 | |
#3 | United States | 6 | |
#4 | Canada | 5 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Machines | |
#3 | Measurement | |
#4 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Haydock Paul V | 15 |
#2 | U Ren Jack | 13 |
#3 | Uren Jack R | 6 |
#4 | Howard Sharon | 6 |
#5 | Gersuk Vivian H | 6 |
#6 | Ray Jason D | 4 |
#7 | Ren Jack U | 3 |
#8 | Haydock Paul | 2 |
Publication | Filing date | Title |
---|---|---|
CA2449968A1 | Nucleic acid amplification utilizing intermediate duplexes | |
US6531300B1 | Target amplification of nucleic acid with mutant RNA polymerase | |
AU1461500A | Methods for preventing cross-contamination in solid support-based assays | |
AU3206199A | A selective assay for determining the identity of live microorganisms in a mixed culture | |
AU2228599A | An exponential nucleic acid amplification method using a single primer of opposing polarity | |
EP1025261A1 | Compositions and methods for determining predisposition to insulin dependent diabetes mellitus | |
US6280945B1 | Universal solid-phase hybridization apparatus | |
US5785925A | Centrifuge tube phase separation plug |